These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30946446)

  • 1. Off-label Treatment in Otolaryngology-A Cautionary Tale.
    Rathi VK; Scangas GA; Gray ST
    JAMA Otolaryngol Head Neck Surg; 2019 May; 145(5):399-400. PubMed ID: 30946446
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label drug and device applications: meeting the challenge.
    Nahai F
    Aesthet Surg J; 2010; 30(3):485-6. PubMed ID: 20601583
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing surgical conflicts of interest.
    Collier R
    CMAJ; 2016 Oct; 188(15):1069. PubMed ID: 27620635
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical device immunity: should promotion of off-label uses leave medical device manufacturers vulnerable to unlimited liability?
    Palmer PG
    J Leg Med; 2014; 35(4):553-77. PubMed ID: 25517635
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approval does not mean what you think it does!
    Dorros G
    J Invasive Cardiol; 2010 Aug; 22(8):382-4. PubMed ID: 20679676
    [No Abstract]   [Full Text] [Related]  

  • 6. Balancing evidence, innovation, and regulation.
    Krouse JH
    Otolaryngol Head Neck Surg; 2015 Apr; 152(4):579-80. PubMed ID: 25833920
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of the Therapeutic Products Act for the ENT practitioner].
    Kaiser R; Ininger G; Stosslein E
    HNO; 2003 Jun; 51(6):513-24; quiz 525-6. PubMed ID: 12858855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where is Consumer Reports when we need it? A clinician's view of surgical innovation.
    Isaacson G
    Otolaryngol Head Neck Surg; 2015 Apr; 152(4):585-6. PubMed ID: 25833923
    [No Abstract]   [Full Text] [Related]  

  • 10. Off-Label Use of Medical Devices in Children.
    ;
    Pediatrics; 2017 Jan; 139(1):. PubMed ID: 28025239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidden truth: The perils and protection of off-label drug and medical device promotion.
    Conko G
    Health Matrix Clevel; 2011; 21(1):149-87. PubMed ID: 21847900
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical Devices; Ear, Nose, and Throat Devices; Classification of the External Upper Esophageal Sphincter Compression Device. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Aug; 80(149):46192-4. PubMed ID: 26242000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label use of drugs and medical devices: a review of policy implications.
    Stafford RS
    Clin Pharmacol Ther; 2012 May; 91(5):920-5. PubMed ID: 22472990
    [No Abstract]   [Full Text] [Related]  

  • 14. Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context.
    Bleicher EW
    Food Drug Law J; 2009; 64(3):531-64. PubMed ID: 19999642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Devices; Ear, Nose, and Throat Devices; Classification of the Tympanic Membrane Contact Hearing Aid. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Jan; 81(13):3325-7. PubMed ID: 26803881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of medical devices in radiology: regulatory standards and recent developments.
    Smith JJ
    J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riegel v. Medtronic, Inc.: revisiting pre-emption for medical devices.
    Patsner B
    J Law Med Ethics; 2009; 37(2):305-17. PubMed ID: 19493075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will new FDA rules hasten device approval?
    Hosp Mater Manage; 2003 Jul; 28(7):2, 16. PubMed ID: 12889277
    [No Abstract]   [Full Text] [Related]  

  • 19. Inappropriate attack on device development.
    Somberg JC
    Am J Ther; 2011; 18(2):91. PubMed ID: 21393999
    [No Abstract]   [Full Text] [Related]  

  • 20. Criminalizing knowledge: the perverse implications of the intended use regulations of off-label promotion prosecutions.
    Gentry G
    Food Drug Law J; 2009; 64(3):441-58. PubMed ID: 19999637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.